Institute and the University of California scientists succeeded the Gladstone, to reprogram human skin cells into fully functional insulin-producing pancreatic cells. The study of the team proves that this new form of cell reprogramming will not only work, but also to an extent could be to produce billions of these cells and to treat these patients with diabetes run.
Existing methods use human stem cells to the breeding of insulin-producing cells to differentiate it to the cells. The team from California’s goal was to find a more effective process. Against this background, the choice of human skin cells as a starting point sense results because they are available in large numbers. The researchers used pharmaceutical chemicals, the so-called endodermal progenitor cells back to duck wrap, which can typically occur in the final breath of the human embryo and develop into different types of tent. End oder male progenitor cells are differentiated to some degree already. So, the researchers took a shortcut, resulting the formation of pancreatic cells very much faster. For the operation, the researchers used different catalysts, which have accelerated the development.
A danger was a possible mishap because of the enormous rate of reproduction of cells, an effect that can be observed inter alia in the development of cancer cells. The cells in the experiment were not malignant abnormalities.